201 related articles for article (PubMed ID: 8719669)
41. Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding.
Trissel LA; Ogundele AB; Ingram DS; Saenz CA; Gentempo JA
Am J Health Syst Pharm; 2003 Sep; 60(18):1853-5. PubMed ID: 14521036
[TBL] [Abstract][Full Text] [Related]
42. Does wearing CBRN-PPE adversely affect the ability for clinicians to accurately, safely, and speedily draw up drugs?
Castle N; Bowen J; Spencer N
Clin Toxicol (Phila); 2010 Jul; 48(6):522-7. PubMed ID: 20550425
[TBL] [Abstract][Full Text] [Related]
43. Bacterial contamination of aerosol solutions containing antibiotics.
Oie S; Kamiya A
Microbios; 1995; 82(331):109-13. PubMed ID: 7541888
[TBL] [Abstract][Full Text] [Related]
44. On the proper sterile technique for handling of propofol.
Sosis MB
Can J Anaesth; 2002 Nov; 49(9):1000. PubMed ID: 12419735
[No Abstract] [Full Text] [Related]
45. Changes in the auditory evoked potentials index by induction doses of four different intravenous anesthetics.
Nishiyama T
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1326-9. PubMed ID: 16146470
[TBL] [Abstract][Full Text] [Related]
46. [Bacterial contamination as a complication of intravenous therapy in intensive care (author's transl)].
Kilian J; Hösch A; Ahnefeld FW; Schmitz JE; Vanek E
Anaesthesist; 1980 Oct; 29(10):559-66. PubMed ID: 7004262
[TBL] [Abstract][Full Text] [Related]
47. Do intensive care drug infusions support microbial growth?
Graystone S; Wells MF; Farrell DJ
Anaesth Intensive Care; 1997 Dec; 25(6):640-2. PubMed ID: 9452846
[TBL] [Abstract][Full Text] [Related]
48. Prevention of transmission of resistant bacteria between periodontal sites during subgingival application of antibiotics.
Preus HR; Lassen J; Aass AM; Christersson LA
J Clin Periodontol; 1993 Apr; 20(4):299-303. PubMed ID: 8473541
[TBL] [Abstract][Full Text] [Related]
49. In-use contamination of propofol. A clinical study.
Bach A; Motsch J; Schmidt H; Böttiger BW; Böhrer H; Martin E; Sonntag HG
Eur J Anaesthesiol; 1997 Mar; 14(2):178-83. PubMed ID: 9088817
[TBL] [Abstract][Full Text] [Related]
50. Direct cardiac effects in isolated perfused rat hearts measured at increasing concentrations of morphine, alfentanil, fentanyl, ketamine, etomidate, thiopentone, midazolam and propofol.
Süzer O; Süzer A; Aykaç Z; Ozüner Z
Eur J Anaesthesiol; 1998 Jul; 15(4):480-5. PubMed ID: 9699107
[TBL] [Abstract][Full Text] [Related]
51. Flow rate, syringe size and architecture are critical to start-up performance of syringe pumps.
Neff SB; Neff TA; Gerber S; Weiss MM
Eur J Anaesthesiol; 2007 Jul; 24(7):602-8. PubMed ID: 17261217
[TBL] [Abstract][Full Text] [Related]
52. [Bacterial contamination of anesthesiologists' hands and the efficacy of handwashing].
Fukada T; Tachibana C; Tsukazaki Y; Satoh K; Furuya Y; Ohe Y
Masui; 1996 Aug; 45(8):1026-30. PubMed ID: 8818106
[TBL] [Abstract][Full Text] [Related]
53. Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks.
Wong CL; Warriner CB; McCormack JP; Clarke AM
Can J Anaesth; 1992 May; 39(5 Pt 1):504-8. PubMed ID: 1596977
[TBL] [Abstract][Full Text] [Related]
54. Quantification of incidental needle and suture contamination during strabismus surgery.
Carothers TS; Coats DK; McCreery KM; Rossman SN; Wilson P; Wu TG; Paysse EA
Binocul Vis Strabismus Q; 2003; 18(2):75-9. PubMed ID: 12765540
[TBL] [Abstract][Full Text] [Related]
55. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion.
Crill CM; Hak EB; Robinson LA; Helms RA
Am J Health Syst Pharm; 2010 Jun; 67(11):914-8. PubMed ID: 20484215
[TBL] [Abstract][Full Text] [Related]
57. Comparison of two methods for detecting microbial contamination in intravenous fluids.
Posey LM; Nutt RE; Thomson PD
Am J Hosp Pharm; 1981 May; 38(5):659-62. PubMed ID: 6792910
[TBL] [Abstract][Full Text] [Related]
58. A microbiological study of the contamination of the syringes used in anaesthesia practice.
Lessard MR; Trépanier CA; Gourdeau M; Denault PH
Can J Anaesth; 1988 Nov; 35(6):567-9. PubMed ID: 3203452
[TBL] [Abstract][Full Text] [Related]
59. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
Stucki C; Sautter AM; Favet J; Bonnabry P
Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
[TBL] [Abstract][Full Text] [Related]
60. Drawing up propofol.
Arnold BD; Bilski AJ
Anaesthesia; 1994 Aug; 49(8):738-9. PubMed ID: 7943722
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
